Clinical Trials · NCT00775684
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University of Pennsylvania
- Enrollment
- 47
- Start date
- Oct 2008
- Locations
- 3 sites, United States
- Primary endpoint
- Effect on Functional Beta-cell Mass as Determined by Change in ß-cell Secretory Capacity at 6 Months (μU/ml)